Age-Related Macular Degeneration

Melatonin use was associated with a decreased risk for both development and progression of age-related macular degeneration among adults aged 50 years or older, according to a study published in JAMA Ophthalmology.

Age-related macular degeneration is the leading cause of vison loss among older adults.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Carolyn Sasse of Astellas highlights the company’s ophthalmology pipeline.

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses a presentation at the ARVO annual meeting on patient preferences for retinal prosthesis options.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Steve Pakola, MD, chief medical officer of Regenxbio, shares updates on the company’s retina programs.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Kester Nahen, PhD, CEO of Notal Vision, discusses the patient self-operated AI-powered Scanly Home OCT device.

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, continues to discuss highlights from the ARVO annual meeting.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Anat Loewenstein, MD, of Tel Aviv Medical Center in Israel, discusses Axpaxli for the treatment of neovascular age-related macular degeneration.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Fred Guerard, CEO of Opthea, shares updates on the COAST and ShORe trials.

SEATTLE — In this video, Eleonora M. Lad, MD, PhD, discusses how targeting abnormalities in Bruch’s membrane in patients with age-related macular degeneration may aid in the development of treatments.